With some recent changes in the economy, interest in growth stocks is back on the rise. If you have available cash to invest, ...

The VERTEX 80 and the VERTEX 80v standard configuration provides apodized spectral resolution that is better than 0.2 cm-1, which is adequate for most room temperature sample measurements and ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of ...

M.D. Ph.D., 50 Northern Ave, Boston, Massachusetts 02210, Chief Scientific Officer, Executive Vice President, Global Research Vertex Pharmaceuticals Incorporated ...

Vertex scored high marks across the core areas of the HDI Support Center Certification ... HDI Support Center Certification ...

Discover Vertex Pharmaceuticals' groundbreaking patent for variant PD-1 polypeptides, enhancing immunomodulatory proteins for innovative cancer and immune therapies.

Kirkland & Ellis is serving as restructuring counsel, Bracewell LLP is serving as restructuring co-counsel, Perella Weinberg Partners is serving as the investment banker, and Alvarez & Marsal is ...

ABOUT VERTEX ENERGY Vertex Energy is a leading energy ... the ability of the Company to obtain low carbon fuel standard (LCFS) credits, and the amounts thereof; the need for additional capital ...

Vertex stock is significantly undervalued due to the underestimated potential of its pain treatment drug, VX-548, which could become a blockbuster. VX-548 has shown to be more effective than ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Vertex Pharmaceuticals, a leader in Cystic Fibrosis treatment, reported strong financials in Q2 but faces limited growth in CF due to high market penetration. Despite a GAAP net loss in Q2, Vertex ...